CVS Health Corporation (CVS)

[FUNMAN]

CVS Health EPS beats by $0.35, beats on revenue, raises guidance • 6:31 AM

CVS Health (NYSE:CVS): Q2 Non-GAAP EPS of $2.42 beats by $0.35; GAAP EPS of $2.10 beats by $0.39.

Revenue of $72.61B (+11.1% Y/Y) beats by $2.34B.

Raised GAAP diluted EPS guidance range to $6.35 to $6.45 from $6.24 to $6.36 vs. $5.47 in FY20

Raised Adjusted EPS guidance range to $7.70 to $7.80 from $7.56 to $7.68 vs. $7.67 consensus.

Raised cash flow from operations guidance range to $12.5 billion to $13.0 billion from $12.0 billion to $12.5 billion vs. $15.9B in FY20